A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.
A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.
复制标题
DOI:
10.1002/mds.28138
复制
发表时间:
2020-10
期刊:
影响因子:
--
通讯作者:
Mikati MA
中科院分区:
文献类型:
--
作者:
Zhang G;Gibson RA;McDonald M;Liang P;Kang PW;Shi J;Yang H;Cui J;Mikati MA
The mutations of KCNMA1 BK type K+ channel have been identified in patients with various movement disorders. The underlying pathophysiology and corresponding therapeutics are lacking. To report our clinical and biophysical characterizations a novel de novo KCNMA1 variant, as well as an effective therapy for the patient’s dystonia-atonia spells. Combination of phenotypic characterization, therapy and biophysical characterization of the patient and her mutation. The patient had more than one hundred dystonia-atonia spells per day with mild cerebellar atrophy. She also had autism spectrum disorder, intellectual disability, and attention deficit hyperactivity disorder. Whole exome sequencing identified a heterozygous de novo BK N536H mutation. Our biophysical characterization demonstrates that N536H is a gain-of-function (GOF) mutation with markedly enhanced voltage dependent activation. Remarkably, administration of dextroamphetamine completely suppressed the dystonia-atonia spells. BK N536H is a GOF that causes dystonia and other neurological symptoms. Our stimulant therapy opens a new avenue to mitigate KCNMA1-linked movement disorders.
登录
查看更多内容
影响因子:
2.5
作者:
Diez-Sampedro, Ana;Silverman, William R.;Richerson, George B.
通讯作者:
Richerson, George B.
影响因子:
5.3
作者:
Lin, Min;Sambo, Danielle;Khoshbouei, Habibeh
通讯作者:
Khoshbouei, Habibeh
影响因子:
3
作者:
Yeşil G;Aralaşmak A;Akyüz E;İçağasıoğlu D;Uygur Şahin T;Bayram Y
通讯作者:
Bayram Y
影响因子:
30.8
作者:
Du, W;Bautista, JF;Wang, QK
通讯作者:
Wang, QK
影响因子:
2.5
作者:
Moldenhauer, Hans J.;Matychak, Katia K.;Meredith, Andrea L.
通讯作者:
Meredith, Andrea L.